Opioid Treatment Claims Linked To Depression Drug Found In Supplements

FDA warns MA Labs and Jack B Goods about online claims that their tianeptine-containing products treat opioid use disorder, pain and anxiety and other violative and unproven claims. CDC reports a jump in poison control center reports on tianeptine, which is approved outside the US to treat depression.

A drug ingredient approved in other countries to treat depression, tianeptine, is the latest substance FDA has found in products marketed as dietary supplements in the US with claims to treat withdrawal from opioid abuse.

More from Regulation

More from Policy & Regulation